Loading...

PODCAST

The BioHub - by Avetix

Max Brennan - Biotech HeadHunter

Welcome to The BioHub, where the doors to the world of biotechnology swing wide open. Join your host, Max Brennan, a seasoned biotech recruiter, as he engages in thought-provoking conversations with the brightest minds in biotech. This podcast is your backstage pass to the insights, strategies, and stories that fuel success in the dynamic and ever-evolving biotech landscape. Subscribe now and be part of the conversation that"s shaping the future of biotechnology. Get ready for an immersive

science life sciences

All Episodes

00:33:51

Episode 241 - Howard Berman & Kia Motesharei - ReAlta...

The BioHub - by Avetix ·

2026/10/06

We were delighted to be joined by two highly experienced leaders in the biotechnology industry, Howard Berman, Ph.D., and Kia Motesharei, Ph.D.Both Howard and Kia have built impressive careers across biotechnology, capital markets, business development and strategic transactions, with a track record of helping companies navigate some of the most important stages of their growth.Howard is now CEO of ReAlta Life Sciences, where he is leading the company through an important clinical-stage period as it

en

00:26:53

Episode 240 - Inder Kaul - CMO at Draig Therapeutics

The BioHub - by Avetix ·

2026/10/05

In this episode of The BioHub Podcast, Ben sits down with Dr. Inder Kaul, Chief Medical Officer at Draig Therapeutics, to discuss the evolution of neuropsychiatric drug development and what it takes to translate novel neuroscience into meaningful medicines for patients.Inder brings decades of global clinical development experience, most recently playing a key role in the development of Cobenfy at Karuna Therapeutics and Bristol Myers Squibb - one of the most significant advances in schizophrenia

en

00:23:58

Episode 239 - Eran Seger - CEO & Co-Founder Protai

The BioHub - by Avetix ·

2026/10/05

In this episode of The BioHub by Avetix, I’m joined by Eran Seger, CEO and Co-Founder of Protai.Eran shares his unique journey into biotech and the inspiration behind founding Protai, where the team is combining proteomics and AI to better understand disease biology and improve how new medicines are discovered.We discuss what makes Protai’s platform different, the realities of being a first-time founder and CEO, the challenge of bringing technology and biotech teams together, and where Eran believes

en

00:27:18

Episode 238 - Mandana Honu Fathom Therapeutics

The BioHub - by Avetix ·

2026/10/01

We welcomed Mandana Honu onto the BioHub podcast

en

00:30:51

Episode 237 - Marc Hedrick & Russell Bradley- Cerenome

The BioHub - by Avetix ·

2026/10/01

In this episode of The BioHub Podcast, Ben is joined by Dr. Marc Hedrick, President & CEO of Cerenome, and Russell Bradley, President & General Manager of CNSide Diagnostics.We explore why CNS cancers remain so difficult to diagnose and treat, and how Cerenome is attempting to address both sides of that problem.Russell takes us inside CNSide®, the company’s cerebrospinal fluid-based diagnostic platform, including how it differs from traditional cytology, the importance of rare-cell

en

00:28:51

Episode 236 - Dan O’Connell - President & CEO of...

The BioHub - by Avetix ·

2026/09/28

In this episode of The BioHub by Avetix, I’m joined by Dan O’Connell, President and CEO of Acumen Pharmaceuticals.Dan shares his journey from neuroscience investing and company creation into the CEO role, and how he has helped take Acumen from a private, preclinical biotech into a publicly traded clinical-stage company focused on Alzheimer’s disease.We discuss the origins of Acumen, what it was like taking the company public with just nine people, navigating a difficult few years for biotech,

en

00:42:26

Episode 235 - Paul Hastings - CEO NKarta

The BioHub - by Avetix ·

2026/09/25

In this episode of The BioHub by Avetix, I’m joined by Paul Hastings, CEO of Nkarta.Paul has spent more than three decades in biotech, leading companies across oncology, rare disease and cell therapy, while also becoming one of the industry’s most prominent patient advocates. At Nkarta, he’s now leading the development of allogeneic NK cell therapies designed to make cell therapy safer, more scalable and more accessible.We discuss the evolution of biotech since Paul entered the industry in 1989, the

en

00:24:59

Epsiode 234 - Lei Fang CEO Excalipoint

The BioHub - by Avetix ·

2026/09/25

We welcomed Lei Fang the CEO of Excalipoint to the BioHub

en

00:35:49

Episode 233 - Jay Fine - President R&D at...

The BioHub - by Avetix ·

2026/09/24

Today we’re joined by Jay Fine, President of Research & Development at EvolveImmune Therapeutics.Jay has spent more than 30 years working across drug discovery and development, with a career spanning immunology, immuno-oncology, inflammatory diseases and respiratory disorders. Before joining EvolveImmune, he spent many years at Boehringer Ingelheim, where he led global research efforts in immunology and respiratory diseases, with his teams playing a key role in advancing therapies including

en

00:23:19

Episode 232 - Alan Bash - President Legend Biotech

The BioHub - by Avetix ·

2026/09/24

Editor’s note: At the time of recording, Alan Bash was serving as Interim CEO of Legend Biotech. He has since resumed his role as President of CARVYKTI® following the appointment of Ingrid Zhang as CEO.In this episode of The BioHub by Avetix, I’m joined by Alan Bash, President of CARVYKTI® at Legend Biotech.Alan shares what drew him to Legend, what he believes has made the company such a standout success in cell therapy, and his experience stepping into the Interim CEO role during an important

en

00:38:31

Episode 231 - Stacy Blain - CEO & Founder of Concarlo...

The BioHub - by Avetix ·

2026/09/22

Today we’re joined by Dr. Stacy Blain, Founder and CEO of Concarlo Therapeutics.Stacy has spent more than 30 years working in cell cycle and cancer biology, including two decades as a tenured professor and NIH-funded researcher at SUNY Downstate. She then made the transition from academia into entrepreneurship, founding Concarlo to develop new approaches to treating drug-resistant cancers.At Concarlo, Stacy and the team are focused on p27 biology and developing their LOCKTAC approach to target CDK2,

en

00:24:22

Episode 230 - Nick Sireau - Chairman at Serenatis Bio

The BioHub - by Avetix ·

2026/09/21

In this episode of The BioHub Podcast by Avetix, Ben O’Keefe sits down with Nick Sireau, Executive Chairman and Co-Founder of Serenatis Bio, to discuss the company’s mission to develop a new generation of treatments for obsessive-compulsive disorder (OCD).Nick shares the deeply personal story behind Serenatis, from his own experience living with OCD to the loss of a close friend to the condition, and how that ultimately helped shape the company’s focus.They explore why OCD remains a significantly

en

00:27:20

Episode 229 - Frederic Marrache - CEO of Bionyra

The BioHub - by Avetix ·

2026/09/21

On this episode we feature the CEO of Bionyra, Frederic Marrache, after closing French-biotech's largest ever Series A ($165million) this summer.Bionyra are a Sofinnova-incubated I&I biotech advancing in-licensed monoclonal (TL1A & IL25) & bispecific (TL1AxIL-23p19) HLE antibodies for a range of autoimmune indications. In this conversation we discuss why, after a decade within Sanofi's I&I development organisation, Frederic viewed the Bionyra opportunity as 'the one' to scratch his

en

00:28:51

Episode 228 - Edward Van Wezel - Founder BGV

The BioHub - by Avetix ·

2026/09/17

In this episode of The BioHub by Avetix, I’m joined by Edward van Wezel, Managing Partner and Co-Founder of BioGeneration Ventures.Edward shares his journey into venture capital and the story behind building BGV into one of Europe’s leading early-stage life sciences investors. We discuss how he evaluates companies at the earliest stages, what he looks for in founders and leadership teams, and the lessons behind standout investments such as Acerta Pharma.We also explore the evolution of the European

en

00:33:17

Episode 227 - Jo Lane - VP People at Compass Pathways

The BioHub - by Avetix ·

2026/09/15

Today, I’m joined by Jo Lane, a senior People and HR leader currently working with COMPASS Pathways, where she plays a key role in supporting the organisation and its people as the company continues to develop and grow.Jo has built an impressive career across the life sciences and healthcare sectors, with senior HR and organisational development roles at COMPASS Pathways, Ipsen and IQVIA. Her experience spans people strategy, organisational development, talent, leadership, change and building

en

00:24:13

Episode 226 - Tony Estrada - CEO & Co-founder Tenvie...

The BioHub - by Avetix ·

2026/09/15

In this episode of The BioHub by Avetix, I’m joined by Tony Estrada, Co-Founder and CEO of Tenvie Therapeutics.Tony shares his journey from Genentech and Denali Therapeutics to founding Tenvie, and why he chose to build a company focused on some of the toughest challenges in neuroscience. We discuss what it takes to launch a biotech in a difficult funding environment, why being scrappy and disciplined matters, and how Tenvie is balancing near-term clinical progress with continued investment in

en

00:35:39

Episode 224 - Wyatt McDonnell - CEO of Infinimmune

The BioHub - by Avetix ·

2026/09/11

On this episode of the podcast we feature CEO & Co-Founder of Infinimmune, Wyatt McDonnell, to discuss a hugely impressive & milestone-rich journey since founding in 2022. Infinimmune was founded on the belief that human disease is best treated with truly human therapeutics. Their discovery platform, developed by Wyatt and his five former 10X Genomics colleagues, has already been tapped by Merck in a partnering deal potentially worth $800million plus. The first two of their immune

en

00:15:31

Episode 223 - Brent Richards -Founder & CEO | 5 Prime...

The BioHub - by Avetix ·

2026/09/10

In this episode of The BioHub Podcast, Amber is joined by Dr. Brent Richards, Founder and CEO of 5 Prime Sciences, a company helping biotech, pharma and investors use human genetics to make better drug development decisions.Brent shares his background in clinical medicine and human genetics, the story behind 5 Prime Sciences, and how genetic evidence can help identify and validate drug targets. We explore the challenges of translating complex data into actionable insights, why understanding causal

en

00:35:44

Episode 221 - Frederic Sweeney - CEO VedaBio

The BioHub - by Avetix ·

2026/09/10

Today I’m joined by Frédéric Sweeney, President and CEO of VedaBio.Fred has spent his career at the intersection of healthcare, diagnostics, venture capital and company building. He’s also been involved with a number of companies as an investor, board member and advisor.Today, Fred is leading VedaBio, which is developing a new approach to molecular diagnostics using CRISPR. The company’s technology is designed to deliver highly accurate molecular detection much faster and closer to the point of

en

00:28:16

Episode 222 - Steve Tregay - Managing General Partner...

The BioHub - by Avetix ·

2026/09/08

In this episode of The BioHub by Avetix, I’m joined by Steve Tregay, Managing General Partner at Mission BioCapital.Steve shares his journey across research, pharma, biotech company building and venture capital, including the story behind founding FORMA Therapeutics and the lessons that experience taught him about creating successful biotech companies.We also discuss how Mission BioCapital approaches early-stage company creation, what Steve looks for in founders and new opportunities, the role big

en

268 results

Similar Podcasts

The Deep Dive Lab: Unraveling Materials Science

Son Hoang

New Books in Political Science

New Books Network

Station 151

Pale Matter | Realm

Beyond the Divide

Koala Moon

StarTalk with Neil deGrasse Tyson

Neil deGrasse Tyson